Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TetraVax-DV in Healthy Adults in Taiwan
NCT03485144Phase 2Completed
- Sponsor
- Medigen Biotechnology
- Start
- Dec 2017
- Primary completion
- May 2019
- Modality
- Live Attenuated Vaccines, Recombinant Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TetraVax-DV in dengue fever, sponsored by Medigen Biotechnology. Started Dec 2017; status: completed.
02
Drugs
TetraVax-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT03485144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03485144.